Nicholas Augustinos - 21 May 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Nicholas Augustinos
Issuer symbol
DXCM
Transactions as of
21 May 2021
Net transactions value
+$0.918
Form type
4
Filing time
25 May 2021, 19:15:54 UTC
Next filing
07 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Other $0 +2,192 +272% $0.000000 2,998 18 Mar 2021 Direct F1, F2
transaction DXCM Common Stock Award $0.918 +918 +31% $0.001000* 3,916 21 May 2021 Direct F3, F4
transaction DXCM Common Stock Other $0 -2,192 -22% $0.000000 7,900 18 Mar 2021 by Trust F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were transferred from ownership under the Kirschner/Augustinos Revocable Trust to direct ownership.
F2 Included in this number are 806 restricted stock units which were granted on May 22, 2020 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2021 Annual Meeting.
F3 The RSU Award was granted on May 21, 2021 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F4 Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting.
F5 Shares are held by the Kirschner/Augustinos Revocable Trust, of which the reporting person is trustee.